Nareg Sagherian | ED, IR |
Jerome Durso | President and CEO |
Andrew Saik | CFO |
Linda Richardson | Chief Commercial Officer |
Michelle Berrey | President of Research & Development and Chief Medical Officer |
Yasmeen Rahimi | Piper Sandler |
Ritu Baral | Cowen |
Thomas Smith | SVB |
Mayank Mamtani | B. Riley |
Jonathan Wolliben | JMP Securities |
Brian Abrahams | RBC Capital Markets |
Michael Yee | Jefferies |
Jay Olson | Oppenheimer |
Brian Skorney | Baird |
Steve Seedhouse | Raymond James |
Joseph Stringer | Needham & Company |
Ellie Merle | UBS |
Good morning, and welcome to Intercept Pharmaceuticals Q1 2022 Earnings Conference Call. At this time all participants are in listen-only mode. [Operator Instructions].
As reminder, today's call is being recorded. I would now turn the conference over your host, Mr.